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Background: Coronary artery bypass is an acceptable therapy in patients with
ischemic cardiomyopathy. However, it has been demonstrated that patients with
increased left ventricular volume have a worse outcome than patients with normal
ventricular volume. Our hypothesis was that ventricular restoration plus coronary
artery bypass provides improved outcome compared with coronary artery bypass
alone in ischemic cardiomyopathy with ventricular enlargement.
Methods: A retrospective analysis was performed of patients with ischemic cardio-
myopathy (ejection fraction 30%) who underwent operation between 1998 and
2002. Patients with enlarged ventricles (end-diastolic dimension 6.0 cm) who
underwent either coronary artery bypass alone or coronary artery bypass with
ventricular restoration were compared. Preoperative and postoperative ejection
fraction, morbidity, mortality, and freedom from heart failure (hospitalization sec-
ondary to heart failure) were assessed.
Results: Ninety-five patients were included in the study. Thirty-nine patients had
coronary artery bypass alone, whereas 56 patients had ventricular restoration with
coronary artery bypass. Both groups demonstrated an improved postoperative
ejection fraction; however, the improvement was significantly greater in the ven-
tricular restoration plus coronary artery bypass group (P  .01). There were no
hospital deaths in either group; however, late mortality was higher in the coronary
artery bypass group. Freedom from heart failure was achieved in all but 2 of the
ventricular restoration plus coronary artery bypass patients (2/56, or 3.6%) versus 7
in the coronary artery bypass group (7/39, or 18%). The combined outcomes of
freedom from failure and late mortality were significantly improved in the ventric-
ular restoration plus coronary artery bypass group (P  .05).
Conclusions: Ventricular restoration affords significant improvement in ejection
fraction compared with coronary artery bypass alone, without added mortality. Most
importantly, left ventricular restoration reduces late morbidity and mortality com-
pared with coronary artery bypass alone in patients with large ventricles.
Heart failure is one of the leading causes of hospitalization in theUnited States, with 400,000 to 700,000 new cases of heart failurediagnosed yearly. Most current therapeutic strategies are focusedtoward resolving the acute exacerbation of failure, resulting in a3-month re-admission rate of 20% to 50% and a devastating 2-yearmortality of 35% to 50%.1,2 Each year, heart failure accounts for 1.5
million hospital admissions, with costs approximating $6000 to $12,000 per admission.2
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Despite optimum medical therapy, some patients remain
refractory to these strategies, and heart transplantation has
become accepted therapy for some patients with severe
heart failure. Not unlike any other form of transplantation,
donor shortages and strict selection criteria limit the number
of heart transplantations performed. The mortality associ-
ated with ischemic cardiomyopathy is related to the pro-
gressive loss of normal elliptical ventricular shape to that of
a dilated ventricle with limited contractile and filling capac-
ity. Although our group3 has demonstrated decreased mor-
tality with revascularization in patients with poor left ven-
tricular function, Yamaguchi and associates4 clearly
demonstrated that overall mortality is related to preopera-
tive left ventricular volume. Specifically, those patients with
ischemic cardiomyopathy and left ventricular (LV) enlarge-
ment who underwent coronary artery bypass (CAB) did
worse than those with small ventricles.
Dor and colleagues5 have demonstrated that ventricular
restoration (VR) can be performed at the time of CAB with
acceptable results. Athanasuleas and associates6 further val-
idated Dor’s institutional experience demonstrating the
safety and efficacy of VR for dilated cardiomyopathy in a
multicenter trial. We postulated that among patients with
severely enlarged and ischemic LVs, improved outcome
could be obtained with the addition of VR to CAB com-
pared with CAB alone. This study compares the clinical
outcomes of patients with severely depressed LV function
who were treated either with CAB and VR or with CAB
alone.
Methods
We retrospectively analyzed the medical records of all patients
with ischemic cardiomyopathy who underwent CAB between
1998 and 2001 at the University of Virginia. Patients with dilated
LVs (end-diastolic dimension 6.0 cm at the tips of the papillary
muscles determined by transthoracic echocardiography) due to
coronary artery disease were included in the study. Ninety-five
patients met these criteria and were included in the study. Patients
with dyskinetic ventricles (LV aneurysms) were excluded. The 95
patients were divided into 2 groups: coronary revascularization
alone (CAB; n  39) and coronary revascularization with VR by
using the Dor technique (CAB plus VR; n  56). Preoperative
ejection fraction (EF), postoperative EF, morbidity, mortality, and
freedom from heart failure (defined as hospitalization secondary to
heart failure) were assessed.
Surgical Technique
Transesophageal echocardiography was used to evaluate preoper-
ative and postoperative LV and mitral valve function. Through a
median sternotomy, the heart was exposed, and after adequate
heparinization, the patient was placed on cardiopulmonary bypass.
Myocardial protection was achieved with antegrade and retrograde
blood cardioplegia.
After complete coronary revascularization (usually in the form
of the internal thoracic artery to the left anterior descending artery
and venous conduits to the remaining ischemic territories), the LV
of the CAB plus VR group was entered. A 2-0 Prolene suture
(Ethicon, Summerville, NJ) was placed around the circumference
of the scar at the transition zone and tied down to restore the
ventricular shape and volume. The location of this exclusion stitch
(Fontan stitch) was determined before surgery by using echocar-
diography and ventriculograms to identify akinetic regions. Echo-
cardiographic ventricular dimensions were obtained in both systole
and diastole in the parasternal short axis view at the tips of the
papillary muscles. An end-diastolic dimension 5.6 cm is consis-
tent with American Society of Echocardiography criteria for a
significantly enlarged ventricular volume. This study excluded
patients with LV aneurysms (irregularity of LV shape) and there-
fore allowed a simplistic ventricular volume calculation based on
the cross-sectional area and the length of the ventricle (volume 
5/6 AL, where A is the cross-sectional area of a short-axis view at
the tips of the papillary muscles and L is the long-axis view from
the apex to the mitral annulus).7 Because patients with asymmetric
or aneurysmal ventricles were excluded, the measured distance
between the papillary muscles is indicative of global dilation of the
LV. Echocardiography and ventriculograms allow a practical and
repeatable measure to determine the ventricular dimension, as well
as specific areas of akinesia, which are subsequently excluded.
Typically we reduce the internal dimension of the ventricle to
approximately 4 to 5 cm at the tips of the papillary muscles. A
synthetic or pericardial patch was then secured over the ventricular
opening with a running suture. The patch was carefully placed not
only to reduce ventricular volume in the long axis, but also to
restore elliptical shape to the dilated, often spherical, LV. Elliptical
shape was achieved by placing the patch in an oblique plane to the
mitral annulus. The edges of the ventricular free wall were then
approximated by using mattress sutures and reinforced with run-
ning 3-0 Prolene. The patients were then weaned from cardiopul-
monary bypass in standard fashion. Transesophageal echocardiog-
raphy confirmed contractility, mitral valve function, and
ventricular size. All patients recovered in the thoracic and cardio-
vascular postoperative unit and were discharged home on angio-
tensin-converting enzyme inhibitors per protocol unless this was
contraindicated. Postoperative transthoracic echocardiographic
data were obtained before discharge in most patients.
Statistical Analysis
Statistical analysis between the 2 groups was performed with a
2-sample Student t test. All P values are 2 tailed. The results are
presented as means  SD.
Results
There were no significant preoperative differences between
the 2 groups with regard to age, sex, New York Heart
Association functional status, LV dimension, or EF (Table
1). There were, however, differences in urgency of opera-
tion and indication for operation; significantly more patients
in the CAB plus VR group presented in cardiogenic shock.
There was no significant difference in preoperative moder-
ate to severe mitral regurgitation (MR) between groups
(Table 2). There were no operative differences between the
2 groups with regard to reoperation, number of bypasses
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performed, ischemic time, or postoperative intra-aortic bal-
loon pump use. Thirty-six patients required concomitant
mitral valve repair (22 in the CAB group and 14 in the CAB
plus VR group; Table 3). The senior author (I.L.K.) per-
formed most of the operations in both the CAB and the
CAB plus VR groups.
After surgery, both groups exhibited a significant im-
provement in LV function as determined by echocardiog-
raphy; however, the degree of LV functional improvement
was significantly higher in the CAB plus VR group (33.43%
 1.22%) than in the CAB group (29.03%  0.61%; P 
.01; Figure 1). Morbidity included atrial or ventricular ar-
rhythmias (or both) in 8 (20.5%) of 39 CAB patients versus
14 (25%) of 56 CAB plus VR patients (P .78). There was
no additional morbidity associated with these arrhythmias;
however, 3 CAB plus VR patients required defibrillator
implantation, and 1 patient required ablation for persistent
ventricular tachycardia. All 36 patients who underwent mi-
tral valve repair (mean LV end-diastolic volume, 199  14
mL) had significant improvement in LV and valve function.
With the exception of 1 patient (CAB plus VR), all patients
had trace to no demonstrable postoperative MR. The 1
patient with persistent MR eventually went on to successful
transplantation 11 months after surgery. Twelve-month
freedom from heart failure was significantly improved in the
CAB plus VR patients (96.5%) compared with the CAB
group (82%; P  .05). There were 2 moderate-term (12-
month) failures in the CAB plus VR group. One of these
patients died 10 months later of renal failure, whereas the
other (mentioned previously) went on to successful heart
transplantation 11 months after VR. These patients did not
undergo a mitral valve repair, yet moderate to severe MR
developed in both in the months after the operation. There
was no operative mortality for either group, yet late mor-
tality (6-24 months) occurred in 2 CAB patients (5.1%). The
LV end-diastolic volumes of these 2 patients were the
largest in the CAB group (213 and 209 mL). Both patients
died of heart failure awaiting cardiac transplantation with
severe MR (Table 4).
Discussion
The complex derangement of LV geometry caused by trans-
mural infarct and/or aneurysm formation poses a number of
problems for a surgeon. Ventricular reconstruction, as de-
scribed by Vincent Dor, has demonstrated improved out-
come in patients with ventricular aneurysms.5,8,9 Dor and
others have also demonstrated that equivalent results could
be achieved with VR even in patients without discrete
ventricular aneurysms.6,9 Our group has demonstrated that
TABLE 3. Operative comparison data
Variable CAB (n  39) CAB  VR (n  56)
Number of coronary grafts* 3.4 0.8 2.6 1.0
Mitral valve repair 22 14
Ischemic time (min) 81 22 90 28
CPB time (min) 104 16 135 28
Operative mortality 0 0
CAB, Coronary artery bypass; VR, ventricular restoration; CPB, cardiopul-
monary bypass.
*Left internal thoracic artery to left anterior descending artery; venous
conduits to other ischemic territories.
Figure 1. A comparison of the improvement in LV function be-
tween the CAB and CAB  VR groups.
TABLE 1. Preoperative comparison data
Variable CAB (n  39) CAB  VR (n  56)
Age (y) 68.4 5.1 63.1 6.2
Sex 31 M, 8 F 42 M, 14 F
Preoperative EF (%) 25.8 0.7 22.1 1.1
LVedD (cm) 6.4 0.3 6.5 0.3
LVedV (mL) 194 24 201 21
NYHA class III-IV 37 55
Mitral regurgitation 2 22 30
CAB, Coronary artery bypass; VR, ventricular restoration; EF, ejection
fraction; LVedD, left ventricular end-diastolic dimension; LVedV, left ven-
tricular end-diastolic volume; NYHA, New York Heart Association.
TABLE 2. Indications for operation
Variable CAB (n  39) CAB  VR (n  56)
Unstable angina alone 22 20
CHF alone 8 14
Angina and CHF 9 16
Shock* 0 6†
CAB, Coronary artery bypass; VR, ventricular restoration; CHF, congestive
heart failure.
*Shock indicates hemodynamically lability necessitating emergency oper-
ation.
†P  .05.
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patients with severely depressed LV function due to dilated
cardiomyopathy (nonaneurysmal disease) can experience
significant improvement by restoration of the elliptical
shape of the LV.
It is well known that low EF (20%) predicts higher
mortality in patients with poor systolic function after CAB.
It has also become increasingly evident that ventricular
volume is a strong predictor of outcome after myocardial
infarction and reperfusion.4 The Global Utilization of Strep-
tokinase and t-PA for Occluded Coronary Arteries data
clearly demonstrate that large ventricular volume strongly
predicts adverse outcomes, including early and late mortal-
ity.10
Investigators have suggested that patients with both isch-
emic cardiomyopathy and significant LV dilation should
undergo transplantation secondary to poor outcome after
CAB.11 However, is cardiac transplantation the best solu-
tion for ischemic cardiomyopathy with severely dilated and
poorly functioning ventricles? Aziz and associates12 ad-
dressed this issue by comparing the outcomes of cardiac
transplantation between patients with ischemic cardiomy-
opathy and those with idiopathic cardiomyopathy. Although
the operative mortality between the 2 groups was essentially
the same (11.2% and 10.6%, respectively), the 10-year
survival was remarkably different: 39% and 80% (P .001)
for ischemic and idiopathic cardiomyopathy, respectively.
The decision to operate on patients with severely de-
pressed LV function is not straightforward. There is con-
troversy regarding the lower limit in terms of acceptable
preoperative EF in patients being considered for bypass
surgery. Our group and others believe that EF provides
some frame of reference to LV function, yet it does not
dictate our operative management.13,14 Although low EF is
an indicator of poor outcome, it is not in itself a contrain-
dication to CAB, nor does EF necessarily relate to ventric-
ular volume, which is far more predictive of outcome.15,16
We cannot deny the aforementioned relationship between
LV function, specifically EF, and postoperative morbidity
and mortality. We, however, aim to reduce wall tension by
reducing chamber size and favorably altering the oxygen
supply-demand ratio of the remote muscle irrespective of
the preoperative EF. Simply stated, we would not withhold
operative therapy from a patient with ischemic cardiomy-
opathy and critical LV function.
Luciani and associates17 have suggested that preopera-
tive angina may predict good outcome. Our experience has
shown that although this may be true, the lack of angina did
not predict a worse outcome.18 It is important to understand
the distinct difference between a painful muscle that is
ischemic and a dilated heart that, because of a change in
fiber orientation, has impaired function independent of
blood supply. In this study, the lack of angina did not
significantly differ between the 2 groups (25% CAB plus
VR vs 21% CAB) and was not an independent predictor of
survival or heart failure.
Progressive ventricular dilation often distorts critical el-
ements of the mitral apparatus and can result in functional
MR. Therapy for functional MR should be aimed at restor-
ing the normal relationships of the mitral apparatus that
have been distorted by LV remodeling. In patients with
dilated cardiomyopathy and functional MR who are under-
going VR, surgical therapy should address all components
of the mitral apparatus. We completely revascularize all
viable myocardium, restore ventricular volume and shape,
decrease orifice area, and realign the papillary muscles. Di
Donato and colleagues19 have convincingly demonstrated
that late MR after the Dor procedure is associated with poor
prognosis and emphasized early (intraoperative) correction.
Our group and others have demonstrated that relationships
of the mitral apparatus occasionally can be restored by
reducing the area between the widened papillary muscles
with sutures.20,21 Menicanti and colleagues22 have de-
scribed the technique of narrowing the interspace between
the papillary muscles by imbricating sutures while simulta-
neously addressing revascularization and restoring ventric-
ular shape. We do not routinely use this technique; however,
the basic tenet of restoring all components of the mitral
apparatus toward normalcy is clear.
There is little doubt that mitral repair or replacement
should be performed concomitantly with VR when signifi-
cant MR exists; however, it is not established which tech-
nique is most effective.15 In patients who require annulo-
plasty beyond the limits obtained by the Dor procedure, we
routinely use a mitral annuloplasty ring through the atrial
approach and a chordae-shortening technique of suturing
the posterior papillary muscle and chordae to the posterior
ventricular wall to allow proper coaptation of the leaflets.21
This study included 36 patients who required mitral valve
repair (22 CAB and 14 CAB plus VR). Although there were
more patients in the CAB group with MR, we can draw no
TABLE 4. Postoperative comparisons
Variable CAB (n  39) CAB  VR (n  56)
Postoperative EF (%) 29 0.6 33.4 1.2*
Postoperative LVedD 5.8 1.0 4.3 0.3*
Postoperative LVedV (mL) 174 39 119 35*
Operative mortality 0 0
Hospital stay (d) 6.9 1.9 7.9 2.0
Recurrent heart failure 7/39 (18%) 2/56 (4%)*
Long-term mortality 5.1% 1.8%*†
CAB, Coronary artery bypass; VR, ventricular restoration; EF, ejection
fraction; LVedD, left ventricular end-diastolic dimension; LVedV, left ven-
tricular end-diastolic volume.
*P  .05.
†Although recurrent heart failure was the end point for this analysis (n 
2 in the CAB VR group), mortality is reported for interest. One patient had
successful heart transplantation.
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hard conclusions that this observation accounts for differ-
ences in outcome between the 2 groups. The clinical effect
of restoring elliptical ventricular shape and re-establishing
normalcy to the mitral apparatus cannot be ignored.
We reviewed mitral valve function after VR in an earlier
series of patients who underwent VR at our institution.16
Improvement in functional MR was observed in 64% of
patients despite no mitral intervention. This amelioration of
mitral insufficiency after the Dor procedure is related to the
reshaped ventricle as described by Buckberg and Athana-
suleas.23 Restoration of the LV geometry results in a nar-
rower configuration of papillary muscles, with an improve-
ment in the degree of mitral insufficiency. However, the
long-term effects of this reshaped geometry and the realign-
ment of the mitral apparatus need to be elucidated.
The relationship between improvement in LV perfor-
mance and symptomatic improvement is not clear.24 Al-
though improvements in LV function after VR may not
always be profound, most patients still experience symp-
tomatic improvement. Luciani and associates25 demon-
strated that despite improved EF, late functional outcome
after CAB in patients with ischemic dilated cardiomyopathy
remains suboptimal with recurrent congestive heart failure.
This observation, as well as our own data, demonstrates that
a reduction in ventricular volume is a central feature of
improvement. We noted symptomatic improvement in all
but 1 patient (CAB plus VR) regardless of postoperative
objective EF changes.
When the extent of myocardial exclusion is determined,
the morphology of the lesion must be appreciated, and areas
of akinesia or dyskinesia must be recognized. With in-
creased use of thrombolysis and angioplasty, the classic
appearance of a thin, scarred myocardium that collapses
with ventricular venting may not be evident. In fact, the
epicardium often appears normal, with somewhat thickened
muscle in the anterior apical segment. It is crucial to be able
to look beyond the normal-appearing epicardium and ex-
clude the entire segment to delete the midmyocardial and
endocardial scar. There is no doubt that highly sophisticated
volumetric studies, specifically with cardiac magnetic reso-
nance, will help to distinguish subtle differences in LV wall
alterations, as well as accurately quantify preoperative and
postoperative ventricular volumes. To date, we have not
used this modality at our institution for VR data; however,
it may be used in future studies. We typically rely on
preoperative transthoracic echocardiography that is closely
cross-referenced with left ventriculogram information.
Some authors prefer the beating-heart digital palpation tech-
nique to distinguish the border zone between healthy and
damaged myocardium.26 Our group, however, has recently
demonstrated that the beating-heart technique provides no
additional benefit compared with preoperative determina-
tion of myocardial exclusion.27
The primary goal of this project was to review our
institutional experience with surgical treatment of dilated
cardiomyopathy. The study was retrospective and compared
a surgical technique (CAB) used primarily in the earlier part
of this experience with one (CAB plus VR) used mostly in
the latter half of the study. Whereas echocardiography and
ventriculograms were performed in most patients before
surgery, ventriculography was not routinely used in the
postoperative period. Follow-up EFs and ventricular vol-
umes were mostly assessed by transthoracic echocardiogra-
phy in ambulatory patients; however, these data were not
obtained at precisely the same postoperative intervals
(range, 7-35 days after surgery). Mitral annular size and
papillary muscle width were not measured in all patients.
Some patients have reversible ischemic LV dysfunction
that improves after coronary revascularization. Although
myocardial viability was not quantified before surgery in
every patient, the effect of myocardial hibernation is mini-
mized in the early postoperative period, when we reported
the LV functional improvement.
Conclusions
Although this study is retrospective and observational and is
subject to inherent bias, it does begin to answer how to treat
the patient with a large ventricle and ischemic cardiomyop-
athy. Yamaguchi and associates4 and White and col-
leagues28 have clearly demonstrated the grave prognosis of
patients with large ventricular volumes. We have demon-
strated excellent short-term results with CAB alone but
inferior mid-term results compared with CAB plus VR. The
National Institutes of Health–funded Surgical Treatments
for IsChemic Heart failure trial has been designed to pro-
vide more information on this challenging group of patients.
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Discussion
Dr Andrew S. Wechsler (Philadelphia, Pa). [This discussion
was prepared by Dr Wechsler but was presented by the moderator
in his stead.] Dr Maxey and his colleagues from rural Virginia are
to be commended for outstanding results in a challenging cohort of
patients. More specifically, there were 2 cohorts of patients, and
the task of the reader or listener is to discern whether or not there
is enough evidence presented to make one believe that 1 treatment
strategy was better than the other. To aid in that task, I have several
questions. (1) In providing the data for “recurrent heart failure,”
were the measurements made after the same number of months?
The coronary bypass–alone group was followed up longer than the
CAB plus ventricular restoration group. Are early, 6-month, and
later data available? (2) How long after operation did mortality in
the 2 groups occur? Would it have been better to plot freedom
from death versus time?
I’ll let you respond to those, and then he has a couple of others.
Dr Maxey. Thank you very much. Certainly these are very
valid questions for this type of study. As far as the time period
from recurrent heart failure, due to the span of the study, some of
the patients that were in the CAB-alone group were in the earlier
parts of the study. We have continued to adopt a more liberal
approach to ventricular remodeling techniques. Regarding the pa-
tients that died that you were questioning in the ventricular recon-
struction group: 1 patient received a successful transplant at 10
months, and 1 patient died at 11 months. The deaths in the
CAB-alone group spanned from a 4-month period to a 16-month
period, and I do not have the specifics of the individual death time
points there.
MODERATOR. Question number 3. I’m surprised by the
greatly reduced use of mitral valve repair in the CAB plus ven-
tricular restoration group. If one did logistic regression analysis, I
suspect that the mitral valve repair would be associated with worse
outcome and greater postoperative dimensions. This represents
how statistics that prove association rather than causality can be
confusing. Unfortunately, it also raises the inherent difficulties in
assessing treatment outcomes in nonrandomized studies.
Another question: are data available for the presence or absence
of mitral valve leakage in each group at the time of follow-up?
Dr Maxey. That is correct. Both groups of patients received
noninotropic supported transthoracic echocardiography in the
postoperative period. At that time, mitral valve competence was
analyzed.
MODERATOR. And the final question: In the manuscript, the
authors mentioned their technique of shortening cords to decrease
mitral regurgitation by moving the posterior papillary muscle
closer to the ventricular wall. In my experience, the mitral leakage
is almost always due to tethering of the posterior leaflet. Is it
possible that the maneuver described functionally lengthens the
chordae, allowing greater posterior leaflet mobility?
Dr Maxey. Yes. I think that is correct. We have previously
published our results with this technique. We use it concomitantly
with a semirigid ring, specifically in Carpentier IIIb disease, with
a fair amount of success, and we have published that data.
Dr Robert Robbins (Stanford, Calif). I know we are behind,
but I just wanted—I was telling Irv there is an interesting paper
from a group in the Netherlands—the senior author is Jerome
Bachs(?)—that asks why patients with hibernating myocardium do
not get better after CAB, and his answer was because the ones that
have the large ventricular volumes don’t get better. My question is,
do you have any data on whether hibernating myocardium played
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a role in your results? For instance, if the patients with the CAB 
VR had more hibernating myocardium than the others, you would
expect that this group of patients would have done better.
And just 1 quick comment about the volume. I think most
people would say now that magnetic resonance imaging is a better
way to get volume, so you might want to just say something about
that.
Dr Maxey. Certainly. I’ll answer your last question first if I
may. This was a preliminary study. The echocardiographic evi-
dence that we used, as I mentioned, was very simple. I think that
in the future, as this program progresses, certainly there is a role
for cardiac magnetic resonance or better imaging techniques to
evaluate ventricular volumes.
I am familiar with the study that you mentioned regarding
hibernation. I don’t think that that had an effect in our particular
patient population, because our LV function data were recorded
just prior to discharge—in other words, early on in these patients’
postoperative course. To further define the role of hibernating
myocardium, we will need to reevaluate all study patients’ LV
function further out in their postoperative course.
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